Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01260
|
|||||
| Drug Name |
Tadalafil
|
|||||
| Synonyms |
(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione; (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione; (6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione; ADCIRCA; Acdirca; Cialis; Cialis (TN); Cialis, GF 196960, IC 351, ICOS 351, Tadalafil; GF 196960; GF-196960; IC 351; IC-351; ICOS 351; Ic351; KS-1117; Lilly brand of tadalafil; Tadalafil (JAN/USAN/INN); Tadalafil [USAN]; Tadanafil
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Benign prostatic hyperplasia [ICD11: GA90] | Approved | [1] | |||
| Erectile dysfunction [ICD11: HA01] | Approved | [1] | ||||
| Pulmonary arterial hypertension [ICD11: BB01.0] | Approved | [1] | ||||
| Therapeutic Class |
Antiimpotence Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C22H19N3O4
|
|||||
| Canonical SMILES |
CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
|
|||||
| InChI |
InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8,16,21,23H,9-11H2,1H3/t16-,21-/m1/s1
|
|||||
| InChIKey |
WOXKDUGGOYFFRN-IIBYNOLFSA-N
|
|||||
| CAS Number |
CAS 171596-29-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 389.4 | Topological Polar Surface Area | 74.9 | ||
| Heavy Atom Count | 29 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
2.3
|
|||||
| PubChem CID | ||||||
| PubChem SID |
585746
, 833257
, 7849070
, 7980303
, 10235225
, 12015128
, 14756405
, 14805118
, 26719828
, 44439099
, 46386604
, 46393582
, 46507646
, 46515102
, 48631155
, 49665805
, 49666420
, 49681754
, 50070180
, 50070554
, 50071306
, 50930588
, 53789230
, 57338564
, 71826083
, 92308507
, 103205141
, 104253184
, 104386552
, 118046114
, 124658965
, 124757304
, 124801305
, 124976968
, 125164108
, 126670668
, 126730649
, 129612837
, 131407413
, 134337906
, 134358339
, 135067956
, 137002812
, 142183965
, 144075910
, 144206195
, 152031978
, 152344458
, 160709391
, 160821591
|
|||||
| ChEBI ID |
CHEBI:71940
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Tadalafil was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | In Vitro P-Glycoprotein-Mediated Transport of Tadalafil: A Comparison with Sildenafil. Biol Pharm Bull. 2017;40(8):1314-1319. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.